Pramlintide and Atropine Interaction

Drug interaction information between Pramlintide and Atropine.

Pramlintide and Atropine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Pramlintide and Atropine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Pramlintide

Amylin Analog

Drug B

Atropine

Anticholinergic

How They Interact

Both drugs slow down how fast food and medicine move through your stomach. Taking them together can slow your digestion too much.

FDA Label Information

7.3 Drugs Affecting Gastrointestinal Motility Due to its effects on gastric emptying, SYMLIN should not be considered for patients taking medications that alter gastrointestinal motility (e.g., anticholinergic agents such as atropine) or medications that slow the intestinal absorption of nutrients (e.g., alpha-glucosidase inhibitors).

Frequently Asked Questions

What SPL severity band is on file for Pramlintide + Atropine?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Pramlintide has 13 labeled pairs on file vs Atropine's 6. In the minor band specifically: Pramlintide has 4 (also Fluoxetine, Glimepiride, Repaglinide); Atropine has 6 (also Mexiletine, Metoclopramide, Imipramine, Midazolam).

What mechanism field is on file for Pramlintide and Atropine?

Both drugs slow down how fast food and medicine move through your stomach. Taking them together can slow your digestion too much.

Pramlintide's labeled portfolio outnumbers Atropine

SPL source-record counts only. This page's band is minor · classes on file: Pramlintide (Amylin Analog); Atropine (Anticholinergic).

Pramlintide

0 major · 9 moderate · 4 minor · 13 total

Atropine

0 major · 0 moderate · 6 minor · 6 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.